Arcturus Therapeutics Holdings Inc.ARCTNASDAQ
Loading
Revenue ContractionContracting
Percentile Rank79
3Y CAGR-28.8%
5Y CAGR+50.7%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
-28.8%/yr
vs +90.1%/yr prior
5Y CAGR
+50.7%/yr
Recent deceleration
Acceleration
-119.0pp
Decelerating
Percentile
P79
Within normal range
vs 5Y Ago
7.8x
Strong expansion
Streak
3 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$74.12M-46.4%
2024$138.39M-12.3%
2023$157.75M-23.3%
2022$205.75M+1564.8%
2021$12.36M+29.6%
2020$9.54M-54.1%
2019$20.79M+32.0%
2018$15.75M+21.2%
2017$13.00M-36.2%
2016$20.38M-